|
1. 1. Forouzanfar MH, Sepanlou SG, Shahraz S, Dicker D, Naghavi P, Pourmalek F, et al. Evaluating causes of death and morbidity in Iran, global burden of diseases, injuries, and risk factors study 2010. Arch Iran Med 2014 May;17(5): 304-20. 2. 2. Danaei G, Farzadfar F, Kelishadi R, Rashidian A, Rouhani OM, Ahmadnia S, et al. Iran in transition. Lancet 2019 May 25; 393(10184): 1984-2005. 3. 3. Riley L, Guthold R, Cowan M, Savin S, Bhatti L, Armstrong T, et al. The World Health Organization STEPwise approach to noncommunicable disease risk-factor surveillance: methods, challenges, and opportunities. Am J Public Health 2016 Jan; 106(1),74-8. 4. 4. Van Minh H, Oh J, Hoat LN, Lee JK, Williams JS. Millennium development goals in Vietnam: Taking multi-sectoral action to improve health and address the social determinants. Glob Health Action 2016 Feb 29; 9: 31271. 5. 5. Sumaedi S, Sumardjo S. Factors influencing internet usage for health purposes. Clin Gov 2020; 25(3): 205-221. 6. 6. Malarvizhi CA, Jubaira S, Jayashree S. A Study on Preferred IoT Technology for Tracking Aged NCD Patients in Malaysia. Asia Proceedings of Social Sciences 2021;7(2): 222-6. 7. 7. Malarvizhi C, Manzoor SR. Exploring the Significance of IoT-Enabled Health Monitoring and Assistive Systems for Elderly NCD Patients in Malaysia. 2020. Available at: http://www.kmice.cms.net.my/ 8. 8. Alizadeh G, Gholipour K, Dehnavieh R, JafarAbadi MA, Azmin M, Khanijahani A, et al. A Scenario-based and Modeling Study on the Prevention of Heart Attack in Iran: A Mixed Methods Study Protocol. Iran Red Crescent Med J 2020; 22(9): 6-10. 9. 9. Alizadeh G, Gholipour K, Dehnavieh R, JafarAbadi MA, Azmin M, Khanijahani A, et al. A Scenario-based Modelling Study of the Prevention of Myocardial Infarction in Iran. Iran Red Crescent Med J 2020; 22(9): e88. 10. 10. Khosravi Shadmani F, Farzadfar F, Larijani B, Mirzaei M, Haghdoost AA. Trend and projection of mortality rate due to non-communicable diseases in Iran: A modeling study. PloS one 2019; 14(2): e0211622. 11. 11. Roshandel G, Ferlay J, Semnani S, Fazel A, Naeimi-Tabiei M, Ashaari M, et al. Recent cancer incidence trends and short-term predictions in Golestan, Iran 2004-2025. Cancer Epidemiol 2020 Aug; 67: 101728. 12. 12. Valipour AA, Mohammadian M, Ghafari M, Mohammadian-Hafshejani A. Predict the Future Incidence and Mortality of Breast Cancer in Iran from 2012-2035. Iran J Public Health 2017 Apr; 46(4): 579-80. 13. 13. Zahmatkesh B, Keramat A, Alavi N, Khosravi A, Kousha A, Motlagh AG, et al. Breast Cancer Trend in Iran from 2000 to 2009 and Prediction till 2020 using a Trend Analysis Method. Asian Pac J Cancer Prev 2016; 17(3): 1493-8. 14. 14. Roya N, Abbas B. Colorectal cancer trends in Kerman province, the largest province in Iran, with forecasting until 2016. Asian Pac J Cancer Prev 2013; 14(2): 791-3. 15. 15. Alizadehbipanah G. Futures studies on the prevention of heart attack in Iran. PhD Thesis, Tabriz: Tabriz University of Medical Sciences; 2021. [In Persian] 16. 16. Imani A, Dastgiri S, Zeinalhajlu AA. Population Aging and Burden of Diseases (A Review). Depiction of Health 2015; 6(2): 54. [In Persian] 17. 17. Asadi Noghabi A, Alhani F, Peyrovi H. The Concept of Health in Elderly People: A Literature Review. Iran Journal of Nursing 2012; 25(78): 62-71. [In Persian] 18. 18. Khosravi A, Chaman R. Epidemiological transition and change in health. Knowledge and Health in Basic Medical Sciences 2015; 5(1): 67. [In Persian] 19. 19. Amerzadeh M, Salavati S, Takian A, Namaki S, Asadi-Lari M, Delpisheh A, et al. Proactive agenda setting in creation and approval of national action plan for prevention and control of non-communicable diseases in Iran: The use of multiple streams model. J Diabetes Metab Disord 2020: 1-12. 20. 20. Behzadifar M, Mirghaed MT, Aryankhesal A. Primary health care: an important approach for health sector, missed in Iran’s health system evolution plan. Iran J Public Health 2017; 46(9): 1307. 21. 21. Meier T, Gräfe K, Senn F, Sur P, Stangl GI, Dawczynski C, et al. Cardiovascular mortality attributable to dietary risk factors in 51 countries in the WHO European Region from 1990 to 2016: a systematic analysis of the Global Burden of Disease Study. Eur J Epidemiol 2019; 34(1): 37-55. 22. 22. Abedi P, Khosravi S, Mirghafourvand M, Tabrizi JS. The midwife's role in prevention of non-communicable diseases in Iran. J Educ Health Promot 2021; 10: 43. 23. 23. Martinez R, Lloyd-Sherlock P, Soliz P, Ebrahim S, Vega E, Ordunez P, et al. Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990–2017: a population-based study. Lancet Glob Health 2020; 8(4): e511-e23. 24. 24. Malta DC, Duncan BB, Schmidt MI, Teixeira R, Ribeiro ALP, Felisbino-Mendes MS, et al. Trends in mortality due to non-communicable diseases in the Brazilian adult population: national and subnational estimates and projections for 2030. Popul Health Metr 2020; 18(1): 1-14. 25. 25. Aminpour M, Aryankhesal A, Seyfori N. Investigating the Effective Factors on Implementation of World Health Organization Package of Essential Non communicable Disease Interventions for Primary Health Care in Low Resource Settings: A Scoping review. 2020. Available at: https://www.researchsquare.com/article/rs-31010/v1 26. 26. Aminorroaya A, Fattahi N, Azadnajafabad S, Mohammadi E, Jamshidi K, Khalilabad MR, et al. Burden of non-communicable diseases in Iran: past, present, and future. J Diabetes Metab Disord 2020: 1-7. 27. 27. Sepanlou SG, Parsaeian M, Krohn K, Afshin A, Farzadfar F, Roshandel G, et al. Disability-Adjusted Life-Years (DALYs) for 315 diseases and injuries and Healthy Life Expectancy (HALE) in Iran and its neighboring countries, 1990-2015: findings from Global Burden of Disease Study 2015. Arch Iran Med 2017; 20(7): 403-18. 28. 28. Azadnajafabad S, Mohammadi E, Aminorroaya A, Fattahi N, Rezaei S, Haghshenas R, et al. Non-communicable diseases’ risk factors in Iran; a review of the present status and action plans. J Diabetes Metab Disord 2021: 9-21. 29. 29. Bakhtiari A, Takian A, Majdzadeh R, Haghdoost AA. Assessment and prioritization of the WHO “best buys” and other recommended interventions for the prevention and control of non-communicable diseases in Iran. BMC Public Health 2020; 20(1): 1-16. 30. 30. Pardeshi P. Why controlling noncommunicable diseases is key to fighting Covid. 2021. Available at: https://indianexpress.com/article/ opinion/columns/india-covid-situation-second-corona-deaths-noncommunicable-diseases-ayushman-bharat-7340183/
|